|
WO2021067526A1
|
|
Complement inhibitors for treating drug-induced complement-mediated response
|
|
WO2021050850A1
|
|
Methods of measuring copper concentration in biological samples
|
|
WO2021026254A2
|
|
Compositions and methods for preparing factor xa and derivatives
|
|
WO2021026160A1
|
|
Methods for treatment of refractory generalized myasthenia gravis with eculizumab
|
|
WO2020242849A1
|
|
Methods of treating vitiligo using an anti-c5 antibody
|
|
WO2020236695A1
|
|
Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases
|
|
WO2020168079A1
|
|
Dosage and administration of anti-c5 antibodies for treatment of generalized myasthenia gravis
|
|
WO2020154626A1
|
|
Dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus)
|
|
WO2020118011A1
|
|
Anti-alk2 antibodies and uses thereof
|
|
WO2020106724A1
|
|
Methods for treatment of refractory generalized myasthenia gravis in pediatric patients
|
|
WO2020092546A1
|
|
Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditions
|
|
WO2020092549A1
|
|
Subcutaneous dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh)
|
|
WO2020061496A1
|
|
Eculuzimab for the treatment of neuromyelitis opticae
|
|
WO2020041644A1
|
|
Fusion proteins and methods of treating complement dysregulation using the same
|
|
WO2020041638A1
|
|
Complement factor h and fc binding domain fusion proteins
|
|
WO2020033867A2
|
|
Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
|
|
WO2020006266A1
|
|
Methods of producing anti-c5 antibodies
|
|
EP3810187A1
|
|
Antidotes to factor xa inhibitors
|
|
EP3802593A1
|
|
Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) in pediatric patients
|
|
EP3802603A1
|
|
Dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus) in pediatric patients
|
